MHRA company-led drug alert – Melatonin 10mg capsules (IPS Specials)

MHRA company-led drug alert – Melatonin 10mg capsules (IPS Specials)

July 17, 2018

CLDA number: CLDA (18)A/04

Date issued: 17th July 2018

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led drug recall for certain batches of:

Melatonin 10mg capsules (IPS Specials)

MDR number: MDR 022-07/18

IPS Specials is carrying out a company-led recall of two batches at pharmacy and wholesaler level as they have been labelled with an incorrect extended expiry date of 09 Apr 2021 when they should have been labelled as 26 Dec 2017.

To view the alert please visit the GOV.UK website.



Posted in: ,


More Latest News >

Self Care Week 2019

Self Care Week, which is an annual national awareness week that focuses on providing support for self care across communities and families,...

Final CPCS service spec published

Following its passage through the NHS England and NHS Improvement (NHSE&I) internal governance process, the final version of the Community...

Ask PSNC: Flu FAQs

The services team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2019/20. Below are...

PQS: NHSmail FAQs

The general NHSmail national helpdesk at NHS Digital has been receiving a number of queries from community pharmacy contractors about...